Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Name: Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
License: Public Domain

NKGen Biotech, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced solid tumor, metastatic cancer, her2-positive breast cancer, her2-positive gastric cancer, her-2 protein overexpression, esophageal cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 253013
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.